Social networks
817 5,505Activities
Technologies
Entity types
Location
332 Cambridge Science Park Milton Rd, Milton, Cambridge CB4 0WW, UK
Milton
United Kingdom
Employees
Scale: 51-200
Estimated: 46
Engaged corporates
4Added in Motherbase
4 years, 11 months agoGenerate human-specific efficacy and safety data with PhysioMimixTM Single- and Multi-organ Microphysiological Systems.
CN Bio is a leading organ-on-a-chip (OOC) company that enables researchers to improve the accuracy and efficiency of preclinical drug discovery.
Our PhysioMimix® suite of microphysiological systems, 3D-validated cells, consumable plates, and Contract Research Services facilitate the prediction of human responses to drug exposure, in the presence or absence of disease, so that new medicines can be brought to market more rapidly, cost-effectively and using fewer animals.
Utilizing primary cells, our perfused single (Lung, Liver), and multi-organ (Intestine/Liver, Lung/Liver) models recapitulate the microarchitecture, microenvironment and function of their human counterparts in vitro. The approach provides a viable alternative to animal models where translatability to humans is predicted to be poor and for testing advanced drug modalities where human-specific targets and pathways are required. They generate physiologically relevant, human-translatable, mechanistic data that enables researchers to progress only the safest and most efficacious drugs into in vivo animal studies and be better prepared for clinical trials. Please follow us for regular updates.
It starts here.
Organ-on-a-chip, Hepatitis B, drug discovery, liver disease, containment level 3 laboratory, microfluidic cell culture, precision biology, non-alcoholic steatohepatitis, Organ-on-Chip, Preclinical drug discovery, Microphysiological systems, Safety Toxicology, non-alcoholic fatty liver disorder, Contract Research Services, PhysioMimix OOC, Drug-induced liver injury, ADME, disease modeling, 3D cell culture, Aminal alternative, New Alternative approaches, COVID 19, Drug absorption, Drug metabolism, Bioavailability, and Respiratory infection
CN Bio is a world leading organ-on-a-chip company. We empower you to transform drug discovery with our predictive human organ models.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
UK Research and Innovation Public business cluster, Government Administration | UK Research and Innovation Public business cluster, Government Administration | Other 2 Mar 2021 | | |
AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Not capitalistic Partnership Not event 15 Jun 2020 8 Sep 2022 | | |
Cambridge Science Park Real Estate, Startup accelerator & VC | Cambridge Science Park Real Estate, Startup accelerator & VC | Other 16 Dec 2020 27 Nov 2023 | | |
European Space Agency - ESA Defence and Aerospace, Aviation and Aerospace Component Manufacturing | European Space Agency - ESA Defence and Aerospace, Aviation and Aerospace Component Manufacturing | Not capitalistic Partnership Event 26 Mar 2021 | |